OmniAsset
Get app

OmniAsset › Mutual funds › Aditya Birla Sun Life Pharma and Healthcare Fund

Aditya Birla Sun Life Pharma and Healthcare Fund

Sectoral / Thematic fund benchmarked to BSE Healthcare TRI. Every figure below is read from one dated snapshot; what the snapshot cannot prove is left out, never estimated.

Latest NAV2 Sep 202640.84
CategorySectoral / Thematic
PlanDirect · Growth
Launched20 Jun 2019
Risk labelthe scheme's own riskometerVery High
Legal benchmarkSEBI Tier-1BSE Healthcare TRI
Expense ratiodirect plan, a year1.05%
AUM₹181 Cr
Growth of ₹10,000₹19,6062 Sep 2021 to 2 Sep 2026
₹19,794₹16,859₹13,925₹10,990₹8,056Sep 2021Nov 2022Mar 2024Jun 2025Sep 2026
₹19,606 (+14.4% a year) Aditya Birla Sun Life Pharma and Healthcare Fund

Performance (trailing, annualised)

1Y annualised20.27%
3Y annualised23.00%
5Y annualised14.42%

Point-to-point from the fund's own published NAV; a period the history does not span is left out.

SIP returns

SIP 1Y (₹10,000 a month)invested ₹1,20,000 → worth ₹1,39,89631.98%
SIP 3Y (₹10,000 a month)invested ₹3,60,000 → worth ₹4,73,32118.60%
SIP 5Y (₹10,000 a month)invested ₹6,00,000 → worth ₹9,93,86720.29%

₹10,000 on the first of every month, valued at the latest NAV, as an annualised rate (XIRR).

Calendar years

Calendar 202121.36%
Calendar 2022-11.31%
Calendar 202339.58%
Calendar 202437.69%
Calendar 2025-3.09%

Rolling returns

Rolling 1Y · average318 windows since 15 Jul 202023.04%
Rolling 1Y · median17.60%
Rolling 1Y · worst window-13.83%
Rolling 1Y · best window70.50%
Rolling 1Y · windows positive80%
Rolling 3Y · average215 windows since 11 Jul 202219.53%
Rolling 3Y · median19.74%
Rolling 3Y · worst window12.12%
Rolling 3Y · best window27.18%
Rolling 3Y · windows positive100%
Rolling 5Y · average111 windows since 11 Jul 202419.98%
Rolling 5Y · median18.57%
Rolling 5Y · worst window13.66%
Rolling 5Y · best window28.64%
Rolling 5Y · windows positive100%

Every window of that length in the published history, so one lucky start date cannot flatter the fund.

Risk

Volatility (3Y)12.88%
Downside deviation (3Y)8.76%
Maximum drawdown-15.93%

Management

Fund managerMr. Dhaval Shah
Managing since3 Sep 2026

What it holds

SecurityWeight
Sun Pharmaceutical Industries Ltd12.1%
Apollo Hospitals Enterprise Ltd7.3%
JB Chemicals & Pharmaceuticals Ltd4.7%
Torrent Pharmaceuticals Ltd4.7%
Aurobindo Pharma Ltd4.6%
Ajanta Pharma Ltd4.4%
Mankind Pharma Ltd.3.9%
Lupin Ltd3.7%
Sai Life Sciences Ltd.3.5%
Abbott India Ltd3.3%
SectorWeight
Healthcare96.1%
Industrials0.9%
Materials0.8%

Portfolio disclosed: 97.8% by weight.

Related

Source: the OmniAsset signed reference snapshot, as of 3 Sep 2026. Figures are deterministic; missing data is withheld, never estimated. See methodology and data sources. Not investment advice.

Research this fund and compare it — on your device.

Get OmniAsset on Google Play The mutual fund tracker